Multiple sclerosis (MS) is a neuroinflammatory condition that affects the central nervous system and presents with various neurological and cognitive symptoms. Although these symptoms and the disease course of MS can vary considerably among affected individuals, most people with this condition exhibit a progressive accumulation of disability in the later phase of the disease.
This poster provides an overview of the pathophysiological contributions of both the immune system and the nervous system to MS and how these contributions change with disease progression. The poster also highlights the sites of action of the currently available drugs for MS and briefly touches on other therapeutic strategies that are being explored.
Calliope A. Dendrou, Robin J. Franklin and Lars Fugger
